AI assistant
Ipca Laboratories Ltd. — Board/Management Information 2024
Sep 23, 2024
61700_rns_2024-09-23_021cc82d-5c92-4ee8-b386-ab8b15313516.pdf
Board/Management Information
Open in viewerOpens in your device viewer
September 23, 2024
==> picture [105 x 47] intentionally omitted <==
THRU ONLINE FILING
BSE Ltd. Phiroze Jeejeebhoy Towers Dalal Street Mumbai 400 023 Scrip Code – 524494
National Stock Exchange India Limited, Exchange Plaza, C-1, Block-G, Bandra Kurla Complex, Bandra – (East). Mumbai-400051. Scrip Code : IPCALAB
Dear Sirs,
Sub: Notice of Board Meeting and Trading Window Closure
Pursuant to Regulation 29 read with Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Monday, 30[th] September, 2024, to consider, inter-alia, integration and consolidation of the generics formulations business in the US market of M/s. Bayshore Pharmaceuticals LLC (wholly owned step-down subsidiary) into Unichem Pharmaceuticals (USA) Inc. (wholly owned subsidiary of Company’s subsidiary) so as to consolidate all the Ipca Group’s USA generics formulations business under one entity.
Pursuant to the Company’s Code of Conduct to Regulate, Monitor and Report Trading by Insiders, formulated and adopted under the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in shares of the Company for designated persons, directors, insiders and their immediate relatives has been closed from Monday, 23[rd] September 2024 in view of the above meeting of the Board of Directors of the Company.
The window closure will continue from 1[st] October 2024 till 48 hours after declaration of unaudited financial results of the Company for the 2[nd] quarter and half year ended 30[th] September 2024.
You are requested to kindly take this on your records.
Thanking you.
Yours faithfully, For Ipca Laboratories Limited
Digitally signed by Harish Pandurang Kamath DN: c=IN, o=Personal, title=1715, Harish Pandurang pseudonym=585f434c9c014c338904fe5f4cd8762a, 2.5.4.20=955479ec580ea690ffd8de8b74071cf6f1ee247da687a7a Kamath e82030a7ae82c443b, postalCode=400063, st=Maharashtra, serialNumber=72050fb9fadcbc5de6404685117b8355792f5784c7617d9c4cae2a3887d6b809, cn=Harish Pandurang Kamath Date: 2024.09.23 10:22:04 +05'30'
Harish P. Kamath Corporate Counsel & Company Secretary ACS 6792
==> picture [445 x 70] intentionally omitted <==